Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Huang, Ying

Fred Hutchinson Cancer Center
United States

Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-03 Matthew Young, Ph.D.
Huang, Ying

Western University Of Health Sciences
United States

Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol 5R01CA269653-04 Anda Vlad, M.D., Ph.D.
Huang, Yijian

Emory University
United States

Analytic diagnosis methods for disease ruling 1R01CA283687-01A1 Guillermo Marquez, Ph.D.
Huberty, Jennifer Lynne

University Of Texas Hlth Science Center
United States

Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients 5R01CA262041-05 Marjorie Perloff, M.D.
Huh, Warner King

University Of Alabama At Birmingham
United States

Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) 1R01CA279021-01A1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hui, David

University Of Tx Md Anderson Can Ctr
United States

Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology 5R01CA288515-02 Brennan Streck, Ph.D., RN, M.P.H.
Hundley, William Gregory

Wake Forest University Health Sciences
United States

Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment 5R33CA226960-05 Eileen Dimond, R.N., M.S.
Hur, Chin

Columbia University Health Sciences
United States

Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 3R01CA257333-04S1 Matthew Young, Ph.D.
Huttenhower, Curtis

Broad Institute, Inc.
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 1OT2CA297578-01 Asad Umar, D.V.M., Ph.D.
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-04 Matthew Young, Ph.D.